Ducressa 1 mg/ml + 5 mg/ml kapi za oko, otopina
| Name | Ducressa 1 mg/ml + 5 mg/ml kapi za oko, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-946413615 |
| Active Substance | natrijev deksametazonfosfat levofloksacin hemihidrat |
| Composition | jedan ml otopine sadrži 1 mg deksametazona (u obliku natrijevog deksametazonfosfata) i 5 mg levofloksacina (u obliku levofloksacin hemihidrata) |
| Pharmaceutical Form | kapi za oko, otopina |
| Manufacturer | Santen Oy, Tampere, Finska |
| Marketing Authorisation Holder | Santen Oy, Niittyhaankatu 20, Tampere, Finska |
| Marketing Authorisation Date | 30.06.2025 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/24-02/105 |
| Registration Number | 381-12-01/286-25-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | S01CA01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
